Filename: U54368 doc8.3d Time: 14:49:57 Date: 25 02 08 Checksum: -1986108007 110 3 Non-current assets held for sale and discontinued operations Non-current assets held for sale On 5 December 2007, BP announced it had signed a memorandum of understanding with Husky Energy Inc. to form an integrated North American oil sands business.
BP will contribute its Toledo renery to a US joint venture in return for Husky contributing its Sunrise eld to a Canadian joint venture.
The transaction is expected to be completed by the end of March 2008.
At 31 December 2007, certain Toledo renery assets and associated liabilities were classied as a disposal group held for sale.
No impairment loss has been recognized in relation to this disposal group.
On 27 June 2006, BP announced its intention to sell the Coryton renery in the UK, following a review of its European renery portfolio, that concluded that the group would optimize its value by focusing on a smaller, but more advantaged, rening portfolio in Europe.
In addition, given the integrated nature of the operations, the bitumen business in the UK was also included with the divestment, along with the Coryton bulk terminal together the Coryton disposal group.
At 31 December 2006, negotiations for the sale were in progress and the assets and associated liabilities were classied as a disposal group held for sale.
No impairment loss was recognized at the time of reclassication of the Coryton disposal group as held for sale nor at 31 December 2006.
The major classes of assets and liabilities of the Toledo and Coryton disposal groups, both reported within the Rening and Marketing segment, classied as held for sale at 31 December 2007 and 2006 respectively, are set out below.
On disposal such foreign exchange differences were recycled to the income statement.
The disposal of the Coryton disposal group was completed in May 2007.
For further information see Note 4.
Discontinued operations The sale of Innovene, BPs olens, derivatives and rening group, to INEOS was completed on 16 December 2005.
The Innovene operations represented a separate major line of business for BP.
As a result of the sale, these operations were treated as discontinued operations for the year ended 31 December 2005.
A single amount was shown on the face of the income statement comprising the post-tax result of discontinued operations and the post-tax loss recognized on the remeasurement to fair value less costs to sell and on disposal of the discontinued operation.
That is, the income and expenses of Innovene are reported separately from the continuing operations of the BP group.
The table below provides further detail of the amount shown in the income statement.
In the cash ow statement, the cash provided by the operating activities of Innovene was separated from that of the rest of the group and reported as a single line item.
Gross proceeds received amounted to $8,477 million.
In 2005, there were selling costs of $120 million and initial closing adjustments of $43 million.
In 2006, there was a final closing adjustment of $34 million.
The remeasurement to fair value less costs to sell resulted in a loss of $775 million before tax $184 million recognized in 2006 and $591 million in 2005.
Financial information for the Innovene operations after group eliminations is presented below.
